Thermodynamics Study on the Theophylline-Nicotinamide Cocrystal

Abstract:

In this paper, the theophylline(TP)-nicotinamide(NCT) cocrystal was chosenas an example for studying the preparation analysis-identification and thermodynamic analysis of cocrystal systems. TP-NCT cocrystal was prepared by the methods of grinding, gringding, slurry and evaporation crystallization respectively. The dependence of the cocrystal solubility on the concentration of cocrystal components in solution were measured and correlatedby cocrystal solubility product. The results indicatethatTP and NCT do not ionize or form complexes in ethanol, and with the temperature increasing, both the solubility of theTP-NCTcocrystal and the solubility product increase.Finally, the ternary phasediagrams for the system of TP-NCT-ethanol at (298.15 and 308.15) K, which can provide the theoretical basis forcrystallization processes, are presented.

• Periodical: Applied Mechanics and Materials (Volume 302)
• Pages: 280-285
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.302.280
• Online since: February 2013
• Authors: Jing Jing Guo, Le Ping Dang, Hong Yuan Wei
• Keywords: Cocrystal, Solubility Product, Ternary Phase Diagram, Theophylline

References

[1] David J. Good, Naír Rodríguez-Hornedo. Cocrystal Eutectic Constants and PredictionofSoubilityBehavior[J]. Cryst. Growth Des. 2010, 10 (3), 1028-1032.

DOI: 10.1021/cg901232h

[2] Peterson, M. L.; Hickey, M. B.; Zaworotko, M. J.; Almarsson, Ö. Expanding the Scope of Crystal Form Evaluation in Pharmaceutical Science[J]. J. Pharm. Pharmaceut. Sci. 2006, 9 (3), 317–326.

[3] Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical Cocrystals[J]. J. Pharm. Sci. 2006, 95, 499–516.

[4] Hickey, M. B.; Peterson, M. L.; Scoppettuolo, L. A.; Morrisette, S. L.; Vetter, A.; Guzm an, H.; Remenar, J. F.; Zhang, Z.; Tawa, M. D.; Haley, S. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur. J. Pharm. Biopharm. 2007, 67 (1), 112 – 119.

DOI: 10.1016/j.ejpb.2006.12.016

[5] Schultheiss, N.; Newman, A. Pharmaceutical Cocrystals and Their Physicochemical Properties. Cryst. Growth Des. 2009, 9 (6), 2950 – 2967.

DOI: 10.1021/cg900129f

[6] Jie Lu, SohrabRohani. Preparation and Characterization of Theophylline-NicotinamideCocrystal[J]. Organic Process Research Development. 2009, 13 (6), 1269-1275.

[7] TraskAV, Motherwell WDS, Jones W. Solvent-dropgrinding: Greenpolymorphcontrolofcocrystallization. ChemCommun. 2004: 890–891.

[8] Trask AV, Jones W. 2005. Crystal engineering of organic cocrystals by the solid-state grinding approach. Top Curr Chem. 2005, 254: 41–70.

DOI: 10.1007/b100995

[9] Abigail Ainouz, Jean-René Authelin, Pascal Billot, and Harvey Lieberman. Modeling and prediction of cocrystal phase diagrams[J]. International Journal of Pharmaceutics, 2009, 374: 82-89.

DOI: 10.1016/j.ijpharm.2009.03.016

[10] MaKang, Zhao Min, Wang Haifeng, Xing Jinjing, Huang Ting. Development and Certification of Theophylline Certified Reference Material[J]. Journal of Instrumental Analysis, 2011, 30(4): 418-424.

[11] Sarah J. Nehm, Barbara Rodríguez-Spong, and Naír Rodríguez-Hornedo. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation[J]. Crystal Growth and Design, 2006, 6(2): 592-600.

DOI: 10.1021/cg0503346

[12] Good, D. J.; Rodríguez-Hornedo, N. R. Solubility Advantage of Pharmaceutical Cocrystals[J]. Cryst. Growth Des. 2009, 9 (5), 2252 – 2264.

DOI: 10.1021/cg801039j

[13] ShenminXu, Leping Dang, and Hongyuan Wei. Solid-liquid phase equilibrium and phase diagram for the ternary carbamazepine-succinic acid ethanol or acetone system at (298. 15 and 308. 15) K[J]. J. Chem. Eng. Data, 2011, 56: 2746-2750.

DOI: 10.1021/je100918d